(Q46456979)

English

Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

0 references

object named as

Rachael McLean

3

0 references

object named as

Peter Herbison

2

0 references

author name string

Mira Harrison-Woolrych

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

Janelle Ashton

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

Jim Slattery

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

publication date

1 January 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

28

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

435-442

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

https://scigraph.springernature.com/pub.10.2165/00002018-200528050-00006

0 references

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arthritis medicines and cardiovascular events--"house of coxibs".

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The New Zealand intensive medicines monitoring programme in pro-active safety surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Merck withdraws arthritis drug worldwide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15853444

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200528050-00006

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15853444

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46456979&oldid=2112490040"